< Terug naar vorige pagina

Publicatie

Central sensitisation: causes, therapies, and terminology

Tijdschriftbijdrage - Brief

is an independent, monthly journal committed to publishing content relevant to rheumatology specialists worldwide, with a focus on studies that advance clinical practice, challenge the status quo, and advocate change in health policy. We invite submissions of clinical research (with a focus on clinical trials), expert reviews, and provocative comment and opinion relating to the diagnosis and classification, management, and prevention of rheumatic diseases, including arthritic, musculoskeletal, and connective tissue diseases, as well as disorders of the immune system. The journal also publishes high-quality human translational studies that are supported by robust clinical data, with priority given to studies that identify potential new therapeutic targets, advance eorts toward precision medicine, or have the potential to directly inform future clinical trials. With a strong clinical focus,
Tijdschrift: The Lancet Rheumatology
ISSN: 2665-9913
Issue: 8
Volume: 3
Jaar van publicatie:2021
BOF-keylabel:ja
IOF-keylabel:ja
BOF-publication weight:10
Authors from:Higher Education
Toegankelijkheid:Closed